To explore the effects of Yoga and Pulmonary Rehabilitation in patients with Interstitial lung disease and examine their molecular basis. - Nil

Central Council for Research in Yoga and Naturopathy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•All participants must have quit smoking at least eight weeks before inclusion into the study.
•Patients with a clinical diagnosis of moderate to severe interstitial lung disease (ILD) having diagnosis of either Sarcoidosis or Hypersenstivity Pneumonitis (HSP) or Idiopathic Pulmonary Fibrosis (IPF) requiring enrollment into pulmonary rehabilitation program for their disease management.

•1.Patients having co-morbidities likely to affect the study parameters like pulmonary artery hypertension, Obesity hypoventilation, any other concomitant respiratory disease etc.
•2.Patients having exercise intolerance due to heart failure, angina pectoris.
•3.Endocrinal disorders such as Diabetes mellitus, thyroid disorder that is likely to cause autonomic dysfunction.
•4.Patients having episode of acute infection in the month preceding induction into the study or during the study period.
•5.Co-morbidities, which make yoga training impossible.
•6.Those with complaints of intermittent claudication / varicose veins and Deep Vein Thrombosis.

发起方

Central Council for Research in Yoga and Naturopathy